[Experiences with antimetabolite therapy of malignant forms of progressive chronic polyarthritis].
D000963:Antimetabolites / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D002908:Chronic Disease; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D006801:Humans; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D013997:Time Factors
D000963:Antimetabolites; D015122:Mercaptopurine; D001379:Azathioprine; D008727:Methotrexate
Erfahrungen mit der Antimetabolitentherapie bei der malignen Form der progredient chronischen Polyarthritis.